Pyridium Shortage: What Providers and Prescribers Need to Know in 2026

Your patients with UTIs know how to recognize the burning, urgency, and discomfort of a lower urinary tract infection. They rely on phenazopyridine (Pyridium) as a critical bridge — providing pain relief within 20 minutes to an hour while antibiotics take effect. When they can't fill that prescription, you hear about it. This post covers what you need to know about phenazopyridine availability in 2026 and how to help patients navigate it.

Current FDA Status: No Declared Shortage

As of 2026, phenazopyridine is not on the FDA's active drug shortage list. It is produced by multiple generic manufacturers in the United States and is available both by prescription (100 mg, 200 mg tablets) and over the counter (95–99.5 mg tablets) under brand names including AZO Urinary Pain Relief, Uristat, and Uricalm.

Despite this, patient-reported difficulty filling prescriptions for phenazopyridine HCl 200 mg tablets is a recurring clinical complaint. Understanding why this happens is key to helping your patients.

Why Patients Struggle to Fill Phenazopyridine Prescriptions

Thin pharmacy inventory. Because phenazopyridine is a short-course medication (2-day use), pharmacies maintain minimal stock. Demand spikes — especially in the summer and fall UTI seasons — can temporarily exhaust local supply.

Brand discontinuation. The original branded Pyridium is no longer actively marketed in the U.S. Some pharmacy systems flag "Pyridium" as discontinued; prescriptions written specifically as "Pyridium" may cause confusion with older pharmacy dispensing systems.

Rx vs. OTC split inventory. The prescription (200 mg) and OTC (95–99.5 mg) formulations are stocked and ordered separately. A pharmacy may appear to be "out" of phenazopyridine in its prescription system while having ample OTC stock in its retail section.

Geographic variation. Rural and underserved areas with fewer pharmacy choices are disproportionately impacted. Urban patients have more options but still report gaps at individual locations.

Clinical Pharmacology Refresher

Phenazopyridine is an azo dye that is rapidly excreted unchanged in the urine (~65% of an oral dose), where it exerts a topical analgesic effect on the urinary tract mucosa. The precise mechanism is not fully established, but it is known to act as a local anesthetic. It has no antibacterial activity and does not modify disease progression.

Key clinical considerations:

Contraindicated in patients with renal insufficiency — the drug accumulates, causing yellow discoloration of skin and sclera

Avoid in G6PD deficiency due to risk of hemolytic anemia

Contraindicated in severe hepatitis

Rare: methemoglobinemia risk at elevated doses or in susceptible patients; increased when combined with prilocaine or benzocaine

Interferes with urine dipstick tests based on color — instruct patients to inform the lab

FDA Pregnancy Category B; avoid during breastfeeding, especially with neonates <1 month or G6PD-deficient infants

Prescribing Guidance to Reduce Fill Difficulty

To reduce the chance your patients can't fill phenazopyridine:

Write the generic name. Write "phenazopyridine HCl 200 mg" rather than "Pyridium" to avoid brand-name confusion in dispensing systems.

Authorize OTC substitution. Add a note to the prescription or advise the patient that OTC phenazopyridine (e.g., AZO Urinary Pain Relief) is an acceptable alternative if the Rx version is unavailable.

Send to high-volume pharmacies. Large-format pharmacies (Walmart, Target, Costco) tend to keep larger quantities on hand than small independents.

Counsel patients on what to do if they can't fill it. Direct patients to check the OTC aisle for AZO, or to use a service like medfinder that calls local pharmacies on their behalf.

When Phenazopyridine Is Contraindicated: Clinical Alternatives

For patients who cannot take phenazopyridine (e.g., renal insufficiency, G6PD deficiency), consider:

Ibuprofen or naproxen: NSAIDs with anti-inflammatory activity; avoid in significant renal impairment.

Acetaminophen: Safer for patients with renal concerns than NSAIDs; provides analgesic but not anti-inflammatory effect.

Opioids (rarely warranted): For severe UTI pain, low-dose opioid analgesics may be appropriate for short-term use in patients who cannot tolerate other options, though this is rarely necessary.

How medfinder Can Help Your Patients

medfinder is a service for patients that calls pharmacies near them to check which ones can fill a given prescription. For time-sensitive prescriptions like phenazopyridine, this removes the burden of patients calling pharmacies while they're symptomatic. You can learn more about referring patients at medfinder.com/providers or see our provider's guide to helping patients find Pyridium.